FOXA1 and prostate carcinoma: Notably, a substantial proportion of prostate cancers, up to 74%, can be attributed to fusions found in ETS-family genes (ERG, ETV1, ETV4, and FLI1) or mutations in genes such as SPOP, FOXA1, or IDH1 [34].